Found: 93
Select item for more details and to access through your institution.
Sorafenib, a multikinase inhibitor, is effective in vitro against non-hodgkin lymphoma and synergizes with the mTOR inhibitor rapamycin.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 3, p. 277, doi. 10.1002/ajh.22263
- By:
- Publication type:
- Article
Early Clinical Development of ARQ 197, a Selective, Non-ATP-Competitive Inhibitor Targeting MET Tyrosine Kinase for the Treatment of Advanced Cancers.
- Published in:
- Oncologist, 2011, v. 16, n. 6, p. 788, doi. 10.1634/theoncologist.2010-0380
- By:
- Publication type:
- Article
Efficacy of immune checkpoint inhibitors in non-small cell lung cancer: A systematic review and meta-analysis.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.955440
- By:
- Publication type:
- Article
Understanding, recognizing, and managing toxicities of targeted anticancer therapies.
- Published in:
- CA: A Cancer Journal for Clinicians, 2013, v. 63, n. 4, p. 249, doi. 10.3322/caac.21184
- By:
- Publication type:
- Article
Novel Agents on the Horizon for Cancer Therapy.
- Published in:
- CA: A Cancer Journal for Clinicians, 2009, v. 59, n. 2, p. 111, doi. 10.3322/caac.20003
- By:
- Publication type:
- Article
Targeting apoptosis pathways in cancer therapy.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Molecular Characterization and Therapeutic Opportunities in KRAS Wildtype Pancreatic Ductal Adenocarcinoma.
- Published in:
- Cancers, 2024, v. 16, n. 10, p. 1861, doi. 10.3390/cancers16101861
- By:
- Publication type:
- Article
A Phase I Study of the Oral Dual-Acting Pan-PI3K/mTOR Inhibitor Bimiralisib in Patients with Advanced Solid Tumors.
- Published in:
- Cancers, 2024, v. 16, n. 6, p. 1137, doi. 10.3390/cancers16061137
- By:
- Publication type:
- Article
T-Cell Engagers in Solid Cancers—Current Landscape and Future Directions.
- Published in:
- Cancers, 2023, v. 15, n. 10, p. 2824, doi. 10.3390/cancers15102824
- By:
- Publication type:
- Article
Quality-of-Life (QOL) during Screening for Phase 1 Trial Studies in Patients with Advanced Solid Tumors and Its Impact on Risk for Serious Adverse Events.
- Published in:
- Cancers, 2017, v. 9, n. 7, p. 73, doi. 10.3390/cancers9070073
- By:
- Publication type:
- Article
Clinical Cancer Therapy: State of the Art – 2009.
- Published in:
- Clinical Cancer Update, 2009, v. 3, n. 1, p. 8, doi. 10.3816/CCR.2009.n.001
- By:
- Publication type:
- Article
Post-licensure safety evaluation of dihydroartemisinin piperaquine in the three major ecological zones across Ghana.
- Published in:
- PLoS ONE, 2017, v. 12, n. 3, p. 1, doi. 10.1371/journal.pone.0174503
- By:
- Publication type:
- Article
Multi-Country Evaluation of Safety of Dihydroartemisinin/Piperaquine Post-Licensure in African Public Hospitals with Electrocardiograms.
- Published in:
- PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0164851
- By:
- Publication type:
- Article
Population Pharmacokinetics of Z‐Endoxifen in Patients With Advanced Solid Tumors.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 9, p. 1121, doi. 10.1002/jcph.2053
- By:
- Publication type:
- Article
Inflation of tumor mutation burden by tumor-only sequencing in under-represented groups.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00164-5
- By:
- Publication type:
- Article
A Phase II Study of Pazopanib in Patients with Malignant Pleural Mesothelioma: NCCTG N0623 (Alliance).
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. 523, doi. 10.1634/theoncologist.2019-0574
- By:
- Publication type:
- Article
Sex Differences in Tolerability to Anti‐Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non‐Small Cell Lung Cancer: Are We All Equal?
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1148, doi. 10.1634/theoncologist.2019-0094
- By:
- Publication type:
- Article
Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical Trials.
- Published in:
- Oncologist, 2019, v. 24, n. 1, p. 96, doi. 10.1634/theoncologist.2017-0687
- By:
- Publication type:
- Article
Validation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials.
- Published in:
- Oncologist, 2017, v. 22, n. 2, p. 189, doi. 10.1634/theoncologist.2016-0121
- By:
- Publication type:
- Article
Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
- Published in:
- Oncologist, 2015, v. 20, n. 6, p. 660, doi. 10.1634/theoncologist.2014-0465
- By:
- Publication type:
- Article
The role of Mcl-1 downregulation in the proapoptotic activity of the multikinase inhibitor BAY 43-9006.
- Published in:
- Oncogene, 2005, v. 24, n. 46, p. 6861, doi. 10.1038/sj.onc.1208841
- By:
- Publication type:
- Article
Impact of disease progression date determination on progression-free survival estimates in advanced lung cancer.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 21, p. 5358, doi. 10.1002/cncr.27528
- By:
- Publication type:
- Article
Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer: findings on the basis of North Central Cancer Treatment Group trials.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 6, p. 1262, doi. 10.1002/cncr.25526
- By:
- Publication type:
- Article
A front-line window of opportunity phase 2 study of sorafenib in patients with advanced nonsmall cell lung cancer: North Central Cancer Treatment Group Study N0326.
- Published in:
- 2010
- By:
- Publication type:
- journal article
A Front-Line Window of Opportunity Phase 2 Study of Sorafenib in Patients With Advanced Nonsmall Cell Lung Cancer.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 24, p. 5686, doi. 10.1002/cncr.25448
- By:
- Publication type:
- Article
Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Prognostic Factors Differ by Tumor Stage for Small Cell Lung Cancer.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 12, p. 2721, doi. 10.1002/cncr.24314
- By:
- Publication type:
- Article
Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim® (dihydroartemisinin/ piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and Tanzania.
- Published in:
- Malaria Journal, 2015, v. 14, n. 1, p. 1, doi. 10.1186/s12936-015-0664-9
- By:
- Publication type:
- Article
Influence of Sociodemographic Factors on Treatment Decisions in Non-Small-Cell Lung Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Prospective observational comparison of clinical outcomes between african-american and caucasian patients receiving second-line treatment with pemetrexed for advanced non-small-cell lung cancer.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Prospective Observational Comparison of Clinical Outcomes Between African-American and Caucasian Patients Receiving Second-Line Treatment With Pemetrexed for Advanced Non—Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2013, v. 14, n. 6, p. 726, doi. 10.1016/j.cllc.2013.06.011
- By:
- Publication type:
- Article
Long-Term Safety and Tolerability of Sorafenib in Patients with Advanced Non-Small-Cell Lung Cancer: A Case-Based Review.
- Published in:
- Clinical Lung Cancer, 2011, v. 12, n. 4, p. 212, doi. 10.1016/j.cllc.2011.03.021
- By:
- Publication type:
- Article
Cooperative Group Research Efforts in Thoracic Malignancies 2009: A Review From the 10th Annual International Lung Cancer Congress.
- Published in:
- Clinical Lung Cancer, 2009, v. 10, n. 6, p. 395, doi. 10.3816/CLC.2009.n.075
- By:
- Publication type:
- Article
Cooperative Group Research Endeavors in Small-Cell Lung Cancer: Current and Future Directions.
- Published in:
- Clinical Lung Cancer, 2009, v. 10, n. 5, p. 322, doi. 10.3816/CLC.2009.n.044
- By:
- Publication type:
- Article
In the clinic: ongoing clinical trials evaluating c-MET-inhibiting drugs.
- Published in:
- Therapeutic Advances in Medical Oncology, 2011, v. 3, n. 1, p. S37, doi. 10.1177/1758834011423403
- By:
- Publication type:
- Article
Oncologists' reflections on patient rights and access to compassionate use drugs: A qualitative interview study from an academic cancer center.
- Published in:
- PLoS ONE, 2021, v. 16, n. 12, p. 1, doi. 10.1371/journal.pone.0261478
- By:
- Publication type:
- Article
Genesis of Peace Education in an Era of Xenophobia and Terrorism: The Case of Africa.
- Published in:
- Journal of Pan African Studies, 2009, v. 2, n. 8, p. 260
- By:
- Publication type:
- Article
Efficacy of focal adhesion kinase inhibition in non-small cell lung cancer with oncogenically activated MAPK pathways.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Disclosure, Accountability and Performance: The Case of Ghanaian Banking Industry.
- Published in:
- International Journal of Management, Accounting & Economics, 2019, v. 6, n. 12, p. 844
- By:
- Publication type:
- Article
Pilot Evaluation of Citalopram for the Treatment of Hot Flashes in Women with Inadequate Benefit from Venlafaxine.
- Published in:
- Journal of Palliative Medicine, 2005, v. 8, n. 5, p. 924, doi. 10.1089/jpm.2005.8.924
- By:
- Publication type:
- Article
A Phase 2 Study of Gemcitabine and Epirubicin for the Treatment of Pleural Mesothelioma.
- Published in:
- Cancer (0008543X), 2008, v. 112, n. 8, p. 1772, doi. 10.1002/cncr.23313
- By:
- Publication type:
- Article
The value of combined‐modality therapy in elderly patients with stage III nonsmall cell lung cancer.
- Published in:
- Cancer (0008543X), 2007, v. 110, n. 2, p. 363
- By:
- Publication type:
- Article
A prognostic model for advanced stage nonsmall cell lung cancer.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 4, p. 781, doi. 10.1002/cncr.22049
- By:
- Publication type:
- Article
A phase II study of bortezomib in the treatment of metastatic malignant melanoma.
- Published in:
- Cancer (0008543X), 2005, v. 103, n. 12, p. 2584
- By:
- Publication type:
- Article
Results of combined‐modality therapy for limited‐stage small cell lung carcinoma in the elderlyAdditional participating institutions include the following: Duluth CCOP, Duluth, MN (Daniel A. Nikcevich, M.D.); Cedar Rapids Oncology Project CCOP, Cedar Rapids, IA (Martin Wiesenfeld, M.D.); Meritcare Hospital CCOP, Fargo, ND (Ralph Levitt, M.D.); Toledo Community Hospital Oncology Program CCOP, Toledo, OH (Paul L. Schaefer, M.D.); Sioux Community Cancer Consortium, Sioux Falls, SD (Loren K. Tschetter, M.D.); Geisinger Clinical Oncology Program, Danville, PA (Suresh Nair, M.D.); Rapid City Regional Oncology Group, Rapid City, SD (Larry P. Ebbert, M.D.); Saskatoon Cancer Center, Saskatoon, Saskatchewan, Canada and Allan Blair Cancer Centre, Regina, Saskatchewan, Canada (Muhammad Salim, M.D.); Scottsdale CCOP, Scottsdale, AZ (Tom R. Fitch, M.D.); Carle Cancer Center CCOP, Urbana, IL (Kendrith M. Rowland, M.D.); Medcenter One Health Systems, Bismarck, ND (Ferdinand Addo, M.D.); Altru Health S
- Published in:
- Cancer (0008543X), 2005, v. 103, n. 11, p. 2349, doi. 10.1002/cncr.21034
- By:
- Publication type:
- Article
Personalized Cancer Treatment: Combination Therapies May Be Key to Hitting Tumor Heterogeneity.
- Published in:
- 2013
- By:
- Publication type:
- Proceeding
Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A phase Ib study of Oraxol (oral paclitaxel and encequidar) in patients with advanced malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2022, v. 90, n. 1, p. 7, doi. 10.1007/s00280-022-04443-1
- By:
- Publication type:
- Article
A phase I pharmacokinetic and safety study of Paclitaxel Injection Concentrate for Nano-dispersion (PICN) alone and in combination with carboplatin in patients with advanced solid malignancies and biliary tract cancers.
- Published in:
- 2021
- By:
- Publication type:
- journal article